Publicacións en colaboración con investigadores/as de Pierre and Marie Curie University (7)

2021

  1. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 3, pp. 1020-1030.e10

  2. Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 4, pp. 1041-1052

  3. Worsening of chronic house-dust-mite-induced respiratory allergies: An observational survey in three European countries

    World Allergy Organization Journal, Vol. 14, Núm. 7

2020

  1. The disease burden in patients with respiratory allergies induced by house dust mites: a year-long observational survey in three European countries

    Clinical and Translational Allergy, Vol. 10, Núm. 1

2017

  1. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 72, Núm. 3, pp. 462-472

2016

  1. "A year-long, fortnightly, observational survey in three European countries of patients with respiratory allergies induced by house dust mites: Methodology, demographics and clinical characteristics"

    BMC Pulmonary Medicine, Vol. 16, Núm. 1

  2. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: Results from the MAGGIC individual patient data meta-analysis

    QJM, Vol. 109, Núm. 6, pp. 377-382